Literature DB >> 2016521

Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease.

C S Via1.   

Abstract

Induction of graft-vs-host disease (GVHD) in the parent-into-F1 model is dependent on the presence of T cells in the donor inoculum. Although in vivo activation of donor T cells in response to F1 alloantigens is thought to be critical to GVHD induction, direct evidence of activated donor T cells has been lacking in this model. In the present study, spleen cells from acute or chronic GVHD mice were studied for evidence of T cell activation at multiple intervals early after GVHD induction. Spleen cells from both acute and chronic GVHD mice exhibited striking elevations in spontaneous proliferation and IL-2 production, which were maximal 24 to 48 h after GVHD induction. Persistent lower levels of spontaneous in vitro activity were observed for spleen cells from mice tested 7 to 9 days after GVHD induction. In both forms of GVHD, increased spontaneous proliferation and IL-2 production were dependent on the presence of donor CD4+ T cells. These results strongly support the presence of activated donor T cells in vivo. Furthermore, these data imply that despite the significant differences in outcome, acute and chronic GVHD share a common early event.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016521

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Authors:  Sarah Cooley; Valarie McCullar; Rosanna Wangen; Tracy L Bergemann; Stephen Spellman; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

Review 2.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Modulation of T-cell responses to alloantigens by TR6/DcR3.

Authors:  J Zhang; T W Salcedo; X Wan; S Ullrich; B Hu; T Gregorio; P Feng; S Qi; H Chen; Y H Cho; Y Li; P A Moore; J Wu
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.

Authors:  Y Kataoka; T Iwasaki; T Kuroiwa; Y Seto; N Iwata; N Hashimoto; A Ogata; T Hamano; E Kakishita
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

5.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

6.  Prevention of murine acute graft-versus-host disease by staphylococcal enterotoxin B treatment.

Authors:  K Takenaka; Y Fujiyama; A Andoh; T Sasaki; Y Amakata; H Matsubara; K Hodohara; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

7.  The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation.

Authors:  R A Puliaev; I A Puliaeva; A E Ryan; C S Via
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2005-12-01

Review 8.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.